In this issue:
Body composition and adverse events in women receiving chemotherapy for EBC
Mammography screening and fatal breast cancers
Victorian mortality trends for mammographic screening and adjuvant therapy
Breast cancer liver metastases surgery registry
Abemaciclib plus trastuzumab +/- fulvestrant in HR+/HER2- patients
A 1-day multidisciplinary clinic on breast cancer treatment
Text messaging and discontinuations during AI treatment of EBC
Predicting response to neoadjuvant chemotherapy and neoendocrine therapy in HR+/HER2- patients
Fiber consumption and breast cancer incidence
ANG1005 for breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases
Please login below to download this issue (PDF)